Improvement of dissolution characteristics of picotamide by cyclodextrin complexationMURA, P; LIGUORI, A; BRAMANTI, G et al.Acta pharmaceutica technologica. 1988, Vol 34, Num 2, pp 77-79, issn 0340-3157Article

Design, synthesis and in vitro activities on anti-platelet aggregation of 4-methoxybenzene-1,3-isophthalamidesXIU JIE LIU; XIN XIN SHI; YONG LIANG ZHONG et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 21, pp 6591-6595, issn 0960-894X, 5 p.Article

Platelet function changes induced by picotamide administration in type II diabetic patientsDAVI, G; BELVEDERE, M; CATALANO, I et al.Thrombotic and haemorrhagic disorders. 1991, Vol 3, Num 1, pp 17-20Article

Inhibition by picotamide of thromboxane production in vitro and ex vivoVIOLI, F; GHISELLI, A; IULIANO, L et al.European journal of clinical pharmacology. 1988, Vol 33, Num 6, pp 599-602, issn 0031-6970Article

In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B₂ productionCATTANEO, M; TENCONI, P. M; LECCHI, A et al.Thrombosis research. 1991, Vol 62, Num 6, pp 717-724, issn 0049-3848Article

Acetylsalicylic acid, BM 13.177 and picotamide improve the survival of endotoxin-infused rabbitsFELDHOFF, C. M; GRESEKE, P; PIETERS, G et al.Thrombosis research. 1988, Vol 52, Num 5, pp 487-492, issn 0049-3848Article

Physical characterization of picotamide monohydrate and anhydrous picotamideBETTINETTI, G; MURA, P; SORRENTI, M et al.Journal of pharmaceutical sciences. 1999, Vol 88, Num 11, pp 1133-1139, issn 0022-3549Article

Binding kinetics and antiplatelet activities of picotamide, a thromboxane A₂ receptor antagonistMODESTI, P. A; CECIONI, I; COLELLA, A et al.British journal of pharmacology. 1994, Vol 112, Num 1, pp 81-86, issn 0007-1188Article

In vitro and ex vivo effects of picotamide, a combined thromboxane A₂-synthase inhibitor and -receptor antagonist, on human plateletsBERRETTINI, M; DE CUNTO, M; PARISE, P et al.European journal of clinical pharmacology. 1990, Vol 39, Num 5, pp 495-500, issn 0031-6970, 6 p.Article

Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole bloodANFOSSI, G; PARISI, S; RUSSO, I et al.Thrombosis research. 1995, Vol 77, Num 5, pp 399-410, issn 0049-3848Article

Safety of picotamide, an antiplatelet agent, in an 18-month, double-blind, placebo-controlled, multicenter trial in 2304 patients with peripheral vascular diseaseVIOLI, F; LONGONI, A; MADERNA, M et al.Current therapeutic research. 1993, Vol 54, Num 1, pp 111-121, issn 0011-393XArticle

Acute reduction of TxA₂ platelet binding sites after in vivo administration of a TxA₂ receptor inhibitorMODESTI, P. A; COLELLA, A; CECIONI, I et al.British journal of clinical pharmacology. 1991, Vol 31, Num 4, pp 439-443, issn 0306-5251, 5 p.Article

Competitive inhibition of platelet thromboxane A₂ receptor binding by picotamideMODESTI, P. A; COLELLA, A; ABBATE, R et al.European journal of pharmacology. 1989, Vol 169, Num 1, pp 85-93, issn 0014-2999Article

Effects of picotamide on release of endothelin-1, thromboxane, and prostacycline after treadmill stress in patients with peripheral artery diseaseSAITTA, A; SARDO, A; BONAIUTO, M et al.Angiology. 1998, Vol 49, Num 11, pp 879-884, issn 0003-3197Article

Effect of picotamide on the calcium mobilization and phospholipase C activation in human plateletsPULCINELLI, F. M; PIGNATELLI, P; RIONDINO, S et al.Thrombosis research. 1994, Vol 74, Num 5, pp 453-461, issn 0049-3848Article

Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppressionGRESELE, P; CORONA, C; ALBERTI, P et al.Thrombosis and haemostasis. 1990, Vol 64, Num 1, pp 80-86, issn 0340-6245, 7 p.Article

Effects of picotamide, an antiplatelet agent, on cardiovascular events in 438 claudicant patients with diabetes : a retrospective analysis of the ADEP studyMILANI, M; LONGONI, A; MADERNA, M et al.British journal of clinical pharmacology. 1996, Vol 42, Num 6, pp 782-785, issn 0306-5251Article

Safety and efficacy of picotamide, a dual anti-thromboxane agent, in patients with thrombocytosis and a previous thromboembolic event : a 1-year observational studyPOGLIANI, E; MILANI, M.Journal of international medical research. 1996, Vol 24, Num 3, pp 311-316, issn 0300-0605, 5 p.Article

Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID studyNERI SERNERI, Gian Gastone; COCCHERI, Sergio; VIOLI, Francesco et al.European heart journal. 2004, Vol 25, Num 20, pp 1845-1852, issn 0195-668X, 8 p.Article

Long-term safety and efficacy of picotamide, a dual-action antithromboxane agent, in diabetic patients with carotid atherosclerosis : A 6-year follow-up studyCOTO, V; OLIVIERO, U; COCOZZA, M et al.Journal of international medical research. 1998, Vol 26, Num 4, pp 200-205, issn 0300-0605Article

Long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patientsGIUSTINA, A; PERINI, P; DESENZANI, P et al.Diabetes (New York, NY). 1998, Vol 47, Num 3, pp 423-430, issn 0012-1797Article

Differential scanning calorimetry in compatibility testing of picotamide with pharmaceutical excipientsMURA, P; BETTINETTI, G. P; FAUCCI, M. T et al.Thermochimica acta. 1998, Vol 321, Num 1-2, pp 59-65, issn 0040-6031Conference Paper

Thermal analysis as a screening technique in preformulation studies of picotamide solid dosage formsMURA, P; FAUCCI, M. T; MANDERIOLI, A et al.Drug development and industrial pharmacy. 1998, Vol 24, Num 8, pp 747-756, issn 0363-9045Article

Picotamide : An inhibitor of the formation and effects of TxA₂MODESTI, P. A.Cardiovascular drug reviews (Print). 1995, Vol 13, Num 4, pp 353-364, issn 0897-5957Article

Effects of picotamide, and antithromboxane agent, on carotid atherosclerotic evolution : a two-year, double-blind, placebo-controlled study in diabetic patientsCOCOZZA, M; PICANO, T; OLIVIERO, U et al.Stroke (1970). 1995, Vol 26, Num 4, pp 597-601, issn 0039-2499Conference Paper